Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

How would AI change manufacturing & packaging processes?

These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care

Ovensa and Celanese to collaborate to advance precision drug delivery

Vial to launch oncology CRO, Arati Rao named as First Advisor

The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.

PMBI first time ever crossed Rs. 100 crore sales in May, 2022

Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024

Ayu Health Hospitals announces t expansion plan in Rajasthan

This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.

FDA approves Roche’s Evrysdi for use in babies under two months with SMA

Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date

Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity

This agreement is in addition to the $92 million filling line expansion announced in November 2021